Clinical trials
Completed Immunologic Deficiency Syndromes trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2018 | 2 |
| 2020 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Yonsei University | 2 |
| AB Biotek | 1 |
| Centagen, Inc. | 1 |
| Centre Hospitalier Universitaire de la Réunion | 1 |
| Johann Wolfgang Goethe University Hospital | 1 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 1 |
| National Center for Research Resources (NCRR) | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Radboud University Medical Center | 1 |
| St. Justine's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immunologic Deficiency Syndromes | 15 |
| Acquired Immunodeficiency Syndrome | 3 |
| HIV Infections | 3 |
| Immune System Diseases | 2 |
| Infections | 2 |
| RNA Virus Infections | 2 |
| Alcohol-Related Disorders | 1 |
| Ataxia Telangiectasia | 1 |
| COVID-19 | 1 |
| Cytokine Release Syndrome | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.